17alphaethynyltestosterone

17alphaethynyltestosterone is a synthetic anabolic-androgenic steroid (AAS). It is a derivative of testosterone, the primary male sex hormone, and is characterized by the addition of an ethynyl group at the 17alpha position. This structural modification enhances its oral bioavailability and metabolic stability compared to unmodified testosterone.

Medically, 17alphaethynyltestosterone has been investigated for various therapeutic applications, including the treatment of androgen deficiency and certain types of anemia. However, its widespread clinical use has been limited due to its potent androgenic effects and potential for adverse side effects. It is not commonly prescribed for medical purposes today.

In the context of performance enhancement, 17alphaethynyltestosterone has been misused by athletes and bodybuilders seeking to increase muscle mass and strength. This usage is considered illegal and is prohibited by major sports organizations and anti-doping agencies. The administration of 17alphaethynyltestosterone, like other AAS, can lead to a range of negative health consequences.

Potential side effects associated with 17alphaethynyltestosterone use can include liver toxicity, cardiovascular problems, hormonal imbalances, and psychological effects. Due to these risks, its non-medical use is strongly discouraged. Information regarding its specific pharmacological profile and research studies can be found in scientific literature and databases.